Mark De Been

Title: Mark De Been: Innovator in Antibody Research

Introduction

Mark De Been is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of immunology, particularly in the development of methods and compositions for treating bacterial infections. His innovative work focuses on neutralizing coagulase activity, which is crucial in combating certain bacterial pathogens.

Latest Patents

Mark De Been holds a patent for "Compositions and methods related to antibodies that neutralize coagulase activity during disease." This patent encompasses methods and compositions aimed at treating or preventing bacterial infections, specifically those caused by certain bacteria. The invention includes methods that provide a passive immune response against these pathogens, utilizing antibodies that bind to Coagulase (Coa). Additionally, the patent details immunogenic compositions that comprise at least one Staphylococcal coagulase R Domain, with a sequence identity of 80% to a specific R Domain.

Career Highlights

Throughout his career, Mark De Been has worked with prestigious institutions, including the University of Chicago and Janssen Pharmaceuticals, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Mark has collaborated with notable colleagues such as Dominique Missiakas and Olaf Schneewind. These partnerships have further enhanced his research and development efforts in the area of antibody therapies.

Conclusion

Mark De Been's innovative work in antibody research has the potential to significantly impact the treatment of bacterial infections. His contributions to the field exemplify the importance of scientific research in developing effective medical solutions.